Medigen Biotechnology Corp. (TPEX:3176)
33.05
-0.05 (-0.15%)
May 8, 2026, 1:30 PM CST
12.61% (1Y)
| Market Cap | 4.60B +22.4% |
| Revenue (ttm) | 1.58B +15.3% |
| Net Income | -108.80M |
| EPS | -0.78 |
| Shares Out | 139.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 405,826 |
| Average Volume | 592,479 |
| Open | 33.45 |
| Previous Close | 33.10 |
| Day's Range | 32.70 - 34.60 |
| 52-Week Range | 28.00 - 35.95 |
| Beta | 0.28 |
| RSI | 54.63 |
| Earnings Date | May 13, 2026 |